Clinical Trials Browser

Phase 2 × Fenretinide × CNS × Clear all

NCT00006080 2018-06-27

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00053326 2013-10-08

Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma

Phase 2 Completed

Neuroblastoma